Real-world evaluation of multimodal treatment practice in older oesophageal cancer patients

医学 模式治疗法 癌症 新辅助治疗 内科学 队列 逻辑回归 化疗 放化疗 外科 肿瘤科 乳腺癌
作者
Tianzheng Shen,Yajie Zhang,Yuqin Cao,Jie Zhang,Hecheng Li
出处
期刊:European Journal of Cardio-Thoracic Surgery [Oxford University Press]
标识
DOI:10.1093/ejcts/ezae329
摘要

Abstract OBJECTIVES Elderly-specific data for multimodal treatment of oesophageal cancer (EC) is lacking. This study aimed to evaluate the safety and efficacy of multimodal treatment in older EC patients and to compare the impact of neoadjuvant chemotherapy (NCT) and neoadjuvant chemoradiotherapy (NCRT). METHODS Patients diagnosed with oesophageal squamous cell carcinoma or adenocarcinoma who received NCT/NCRT were identified in the National Cancer Database (NCDB, 2004–2015). First, we compared baseline and post-treatment characteristics between younger (<70 years) and older patients (≥70 years). Logistic regression was used to investigate risk factors of postoperative mortality. Second, we evaluated the effect of neoadjuvant chemotherapy on postoperative mortality and overall survival in the older cohort. Inverse probability of treatment weights (IPTW) and multivariable analyses were used to compensate for differences in baseline covariates. RESULTS We first compared outcomes of neoadjuvant therapy plus oesophagectomy in 14778 eligible EC patients. The older group experienced higher rates of postoperative mortality at 30 days (5.8%) and 90 days (13.5%) compared to younger patients. Postoperative mortality was significantly related to the Charlson-Deyo score and treatment-related factors including NAT type and minimally invasive technique. Second, among the 3,141 older patients (with a median follow-up of 57.8 months and 2029 deaths), those receiving NCT obtained significantly lower postoperative mortality and improved overall survival compared with NCRT (IPTW-Adjusted P = 0.05; HR, 0.85; 95% Cl, 0.72–0.99). CONCLUSIONS Neoadjuvant therapy plus oesophagectomy carries increased short-term mortality risk in older EC patients. NCT in older EC patients showed lower postoperative mortality but no statistically significant differences in overall survival with a point estimate favoring NCT compared to the NCRT group, making NCT a potential option for consideration in specific cases.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Zzzzzzzzzzz发布了新的文献求助10
刚刚
科研通AI6.4应助黄诺采纳,获得10
刚刚
Hello应助song采纳,获得10
1秒前
burrrrr发布了新的文献求助10
1秒前
彭于晏应助葛广奔采纳,获得10
1秒前
1秒前
科研通AI6.2应助sqq采纳,获得10
4秒前
4秒前
小c关注了科研通微信公众号
5秒前
不喝汽水发布了新的文献求助10
5秒前
273662055完成签到,获得积分10
5秒前
重要鑫磊发布了新的文献求助10
6秒前
7秒前
8秒前
阿里嘎多美羊羊桑完成签到,获得积分10
12秒前
浦老四完成签到,获得积分10
12秒前
Magicer完成签到,获得积分10
13秒前
重要鑫磊完成签到,获得积分10
13秒前
牛牛发布了新的文献求助10
13秒前
13秒前
彭于晏应助自然白安采纳,获得10
13秒前
林jj完成签到,获得积分10
14秒前
赘婿应助ToMoTT采纳,获得10
14秒前
14秒前
阿里完成签到,获得积分10
14秒前
科研通AI6.4应助7777饭采纳,获得10
14秒前
葛优完成签到,获得积分20
16秒前
17秒前
ZYT发布了新的文献求助10
17秒前
18秒前
今后应助感性的又琴采纳,获得10
18秒前
林jj发布了新的文献求助30
18秒前
情怀应助丫头采纳,获得10
18秒前
19秒前
葛优发布了新的文献求助30
20秒前
畅快蓝血完成签到,获得积分10
21秒前
文静跳跳糖完成签到,获得积分10
21秒前
咖喱完成签到,获得积分10
21秒前
22秒前
24秒前
高分求助中
Malcolm Fraser : a biography 700
Signals, Systems, and Signal Processing 610
天津市智库成果选编 600
Climate change and sports: Statistics report on climate change and sports 500
Forced degradation and stability indicating LC method for Letrozole: A stress testing guide 500
Organic Reactions Volume 118 400
A Foreign Missionary on the Long March: The Unpublished Memoirs of Arnolis Hayman of the China Inland Mission 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6466700
求助须知:如何正确求助?哪些是违规求助? 8273079
关于积分的说明 17639686
捐赠科研通 5541627
什么是DOI,文献DOI怎么找? 2907985
邀请新用户注册赠送积分活动 1884975
关于科研通互助平台的介绍 1733109